ENTRY       D11778                      Drug
NAME        Daxdilimab (USAN)
FORMULA     C6378H9860N1708O2028S46
EXACT_MASS  144298.8073
MOL_WEIGHT  144387.7498
SEQUENCE    (Heavy chain)
            QVQLQQSGAE VKKPGASVKV SCKASGYTFT SYGISWVRQA PGQGLEWMGW ISAYNGNTNY
            AQKLQGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARNG LWGWDSDAFD IWGRGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            QSALTQPASV SGSPGQSITI SCTGTSSDVG GYNYVSWYQQ HPGKAPKLMI YDVSNRPSGV
            SNRFSGSKSG NTASLTISGL QAEDEADYYC SSYTSSSTVV FGGGTKVTVL GQPKAAPSVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADSSPVK AGVETTTPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H96, H149-H205, H225-L215, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'215, H'266-H'326, H'372-H'430, L22-L90, L138-L197, L'22-L'90, L'138-L'197)
  TYPE      Peptide
EFFICACY    Immunosuppressant, Anti-Leukocyte immunoglobulin-like receptor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of autoimmune disorders
TARGET      LILRA4 [HSA:23547] [KO:K06512]
  PATHWAY   hsa04380(23547)  Osteoclast differentiation
            hsa04662(23547)  B cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                LILRA4
                 D11778  Daxdilimab (USAN)
DBLINKS     PubChem: 405226644
///
